Company: JUNS
Filing Date: 2025-11-26
Form Type: S-1
Source: 0001493152-25-025204
Chunk: 211

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-26
Form: S-1
Chunk 211
---
 exchange for 49,605 options to purchase common stock and 7,500 restricted stock units, The
options to purchase common stock have a strike price of $1.33. The option had a grant date fair value of $50,000. The Company recorded
a gain on the forgiveness of accrued compensation in the amount of $40,000.

As of December 31, 2024 and 2023, $64,105 and
$67,750, respectively, was due to a Company wholly owned by the Company’s Chief Financial Officer, who also is an option holder.
The amount is included in accrued compensation on the Company’s balance sheets.

Director Independence

Our common stock is listed on the Nasdaq. Under
applicable rules of the Nasdaq, a director will only qualify as an “independent director” if, in the opinion of the listed
company’s board of directors, that person does not have a relationship that would interfere with the exercise of independent judgment
in carrying out the responsibilities of a director. In order to be considered independent for purposes of Rule 10A-3, a member of an audit
committee of a listed company may not, other than in his or her capacity as a member of the audit committee, the board of directors, or
any other board committee, accept, directly or indirectly, any consulting, advisory, or other compensatory fee from the listed company
or any of its subsidiaries or otherwise be an affiliated person of the listed company or any of its subsidiaries.

The Company’s Board has affirmatively determined
that currently three of its seven directors (Christer Rosén, Marshall Hayward, Ph.D., and Alison D. Silva) are non-independent
directors of the Company and four of its seven directors (Nicholas H. Hemmerly, Julie Kampf, Allison W. Brady, and Holger Weis) are independent
directors of the Company as defined in the Nasdaq standards. Therefore, a majority of the members of our Board are independent.

| 120 |

<div align='center'>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.</div>

The following table sets
forth information regarding the beneficial ownership of our common stock as of November 25, 2025 by:

| ● | each person known by us to be the beneficial owner of more than 5% of our outstanding shares of common stock; |
| ● | each of our executive officers and directors that beneficial